Each quarter our team at Locust Walk compiles key statistics and trends on strategic transactions and financings. Our 2020 Year End Report: Global Trends in Biopharma Transactions applies the latest data to analyze current activities in the life science deal...
Locust Walk is a global life science transaction firm. Our integrated team-based approach across capabilities, geographies, and industry segments delivers the right products, the right partners, and the most attractive sources of capital to get the right deals done...
Chris Ehrlich (Kellogg ’98), Managing Director, Global Head of Biopharma at Locust Walk leads emerging biotechnology and biopharma transactions, and will present at Kellogg School of Management on January 17th, 2019. Click here for more information.
Missy Fulton, Vice President, Talent Management at Locust Walk to participate and speak at the BVS event “Women Breaking the Barriers of Science and their Male Champions” on November 14 at Boston Marriott Cambridge. Renowned leaders and scientists from top bio-pharma...
Hayato Watanabe, Senior Vice President, Head if Asia at Locust Walk is attending and also speaking at the upcoming BioCentury 2018 China Healthcare Summit. Contact Hayato to meet with him while he is in Shanghai. The China Summit is a VIP-only event for busy biopharma...
